Pharmacy Benefit Manager Practices

Updated the version header from 'Rerevised' to 'Revised' and changed the description to indicate amendments were adopted on second reading in the Senate.

Removed the '3rd Reading Unamended' date and Senate committee listing, indicating the bill has progressed to a new stage in the legislative process.

Added a new requirement for PBMs to disclose claims-level pharmacy data and income from prohibited sources to health benefit plans within thirty days of notification.

Added multiple co-sponsors to both House and Senate sponsorship lists, expanding the bill's partisan support.

Updated committee assignments to reflect current House and Senate committee structures, adding Senate Health & Human Services and Appropriations committees.

Reformatted bill header and summary sections to indicate this is a revised version incorporating all adopted amendments rather than a pre-amendment draft.

Adjusted line numbering and text formatting throughout the bill body to align with current legislative markup standards, though substantive policy language remains consistent.

Updated prohibited income sources to explicitly include 'net acquisition cost' and 'group purchasing organization revenues' to clarify what PBMs cannot earn.

Added a new provision requiring PBMs to pass income derived from prohibited sources directly to health benefit plan beneficiaries if collected inadvertently.

Changed disclosure requirements to mandate PBMs provide 'PBM credits' to health plans instead of only 'income derived from prohibited sources.'

Reformatted the bill text to include committee amendments and updated header information for the 75th General Assembly.

Added signature block instructions and reorganized bill text layout for final signing process

Corrected minor formatting inconsistencies in section headers and spacing throughout the document

Added new Senate sponsors (Amabile, Bridges, Exum, Hinrichsen, Jodeh, Kipp, Wallace, Weissman) to the bill sponsorship list.

Updated the list of House sponsors to include Velasco and reorganized the order of names to match the amended version.

Reformatted the bill text with updated line numbering and removed summary text that indicated future availability of a reengrossed bill summary.

Added additional co-sponsors to the bill (Bacon, Bird, Boesenecker, Duran, English, Joseph, Lieder, Lindsay, McCluskie, McCormick, Paschal, Sirota, Smith, Stewart K., Valdez, Woodrow, Zokaie).

Updated the bill summary header from 'ENGROSSED' to 'REENGROSSED' and added a note indicating the summary applies to the reengrossed version with amendments adopted on March 17, 2025.

Changed references from 'carrier or self-funded health benefit plan' to 'health benefit plan' to broaden applicability.

Added requirement for PBMs to pass through income derived from prohibited sources to health benefit plan beneficiaries.

Added new subsection requiring PBMs to disclose prescription drug cost information and prohibited income sources to health benefit plans within 30 days of notification.

Modified reimbursement rules to specify that PBMs must be reimbursed for lowering aggregated prescription drug spending and for direct services provided to health benefit plans.

Added provision requiring contracts to include terms that authorize health benefit plans to determine PBM compliance with contract terms without additional fees.